Copyright
©The Author(s) 2022.
World J Gastrointest Pathophysiol. Jan 22, 2022; 13(1): 1-14
Published online Jan 22, 2022. doi: 10.4291/wjgp.v13.i1.1
Published online Jan 22, 2022. doi: 10.4291/wjgp.v13.i1.1
Figure 1 Showing important features of prognostic and diagnostic markers.
Figure 2 Pathway for validation of the biomarkers in hepatocellular carcinoma.
Figure 3 Proposed mechanism of drug development using bioinformatics and molecular knowledge about telomere homeostasis.
Figure 4 Pathways and aims of bioinformatics analysis.
Figure 5 Role of molecular docking from drug discovery to clinical use.
- Citation: El-Nakeep S. Molecular and genetic markers in hepatocellular carcinoma: In silico analysis to clinical validation (current limitations and future promises). World J Gastrointest Pathophysiol 2022; 13(1): 1-14
- URL: https://www.wjgnet.com/2150-5330/full/v13/i1/1.htm
- DOI: https://dx.doi.org/10.4291/wjgp.v13.i1.1